Direct Oral Anticoagulants (DOACs)

Reviewed and revised 11 July 2014

Previously known as: New or Novel Oral Anticoagulants (NOACs)

OVERVIEW

  • New oral anticoagulants (NOACs) are recently introduced medications that provide anticoagulation via the oral route by inhibiting specific clotting factors
  • Examples include:
    • direct thrombin inhibitors e.g. dabigatran
    • oral factor Xa inhibitors e.g. rivaroxaban

ADVANTAGES AND DISADVANTAGES OF NOACs

COMPARISON TABLE

  • see here for pharmacokinetic comparison

CCC Pharmacology Series

LITFL

Journal articles

  • Bauer KA. Pros and cons of new oral anticoagulants. Hematology Am Soc Hematol Educ Program. 2013;2013:464-70. PMID: 24319220. [Free Full Text]

Critical Care

Compendium

Chris is an Intensivist and ECMO specialist at The Alfred ICU, where he is Deputy Director (Education). He is a Clinical Adjunct Associate Professor at Monash University, the Lead for the  Clinician Educator Incubator programme, and a CICM First Part Examiner.

He is an internationally recognised Clinician Educator with a passion for helping clinicians learn and for improving the clinical performance of individuals and collectives. He was one of the founders of the FOAM movement (Free Open-Access Medical education) has been recognised for his contributions to education with awards from ANZICS, ANZAHPE, and ACEM.

His one great achievement is being the father of three amazing children.

On Bluesky, he is @precordialthump.bsky.social and on the site that Elon has screwed up, he is @precordialthump.

| INTENSIVE | RAGE | Resuscitology | SMACC

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.